You are here

  • Home
  • Archive
  • Volume 105, Issue 9
  • SP4 Medicines optimisation in action: the development of a dosing schedule and an extemporaneous formulation of pazopanib to treat a child with a recurrent desmoid tumour of the head and neck

Article info

Article menu

Download PDFPDF

Abstracts from the Neonatal and Paediatric Pharmacists Conference November 2019
Sutton Coldfield, UK
SP4 Medicines optimisation in action: the development of a dosing schedule and an extemporaneous formulation of pazopanib to treat a child with a recurrent desmoid tumour of the head and neck
Free

Authors

Citation

Holden V, Lowey A, Wilkins S, et al
SP4 Medicines optimisation in action: the development of a dosing schedule and an extemporaneous formulation of pazopanib to treat a child with a recurrent desmoid tumour of the head and neck
Archives of Disease in Childhood 2020;105:e2-e3.

Publication history

  • First published August 19, 2020.
Online issue publication 
February 11, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.